Trials / Completed
CompletedNCT01562548
Exploratory Efficacy Study of Guaifenesin in Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Explore the clinical efficacy of 7-day treatment regimens of guaifenesin in order to investigate the evidence that guaifenesin is an effective treatment for upper back/neck/shoulder muscle spasm/stiffness and pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Guaifenesin | high and low dose of Guaifenesin each given twice daily over a 4-day treatment period |
| DRUG | Placebo | no active ingredient |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2012-03-26
- Last updated
- 2014-06-03
- Results posted
- 2014-06-03
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01562548. Inclusion in this directory is not an endorsement.